On this page
What do MOTS-C users report before and after a cycle?
The clearest positive accounts describe a change in how training feels: finishing demanding sessions, maintaining intensity through the week and finding cardio easier. A separate account describes staying leaner during a 40-day routine. The table introduces those experiences; the details below keep each person's timeline and other compounds together.
| When reported | Before / usual experience | Change described | Other context |
|---|---|---|---|
| Early use | Hard deadlifts usually drained the rest of the session. | Completed a two-hour leg workout with energy remaining.4 | Retatrutide also used. |
| Week four | Training intensity usually dropped later in a six-day week. | Easier cardio and final repetitions.1 | BPC also used. |
| About five weeks | Compared cardio with their previous routine. | A modest improvement in cardio.2 | NAD+ also used. |
| A 40-day routine | Compared their appearance during repeated courses. | Felt that they stayed leaner.3 | Alternated courses with SS-31. |
These are public personal accounts, not verified customer testimonials or clinical before-and-after measurements. The writers used their own products and routines; their reports do not establish outcomes for the products displayed on this website.
What changed in cardio, lifting and training stamina?
Week four: more consistent intensity across the training week
The author flapsucker17 described training six days a week and usually feeling the drop in intensity around day four. At the time of their post, cardio felt easier and the last repetitions of weight-training sets were more comfortable. They had started with 1 mg on training days and later reported 2 mg, with little perceived difference between those amounts. A follow-up disclosed concurrent BPC use. The reported change was session quality across the week, rather than a measured increase in muscle mass.1
About five weeks: a smaller, noticeable cardio improvement
mylastvengeance described about five weeks at 1–2 mg three times weekly. They noticed a slight cardio improvement and experimented with 3 mg three times weekly, without a clear additional difference. The author also disclosed NAD+ use. This account describes a modest performance change; it does not provide a quantified pace, distance or VO₂ improvement.2
Early use: finishing a demanding leg session
Comfortable-Cry-4117, a 46-year-old woman, described completing a two-hour leg session after 2 mg, with more energy remaining than usual after hard deadlifts. Retatrutide was also in the routine. An initial 5 mg administration had brought anxiety. The post was an early observation; the every-other-day schedule mentioned afterward was a plan.4
In a separate comment, Flat_Yak_293 described heavier lifting, quicker recovery between sets and energy for cardio after weights at three weeks. That commenter supplied no schedule; the original author's amounts do not apply to them.4
What do MOTS-C before-and-after reports say about fat loss?
The 40-day account is a report of perceived leanness. The commenter 1960s_army_info described using 1 mg daily for 40 days, then alternating with an SS-31 course. They felt they stayed leaner, while energy was largely unchanged. The account gives a clear time period but no paired weight, waist or body-fat measurements.3
A different writer in that discussion, johnny2thumbz, described better energy, endurance and more weight loss during a second cycle. Their stated schedule was about 3.33 mg three times weekly; 5 mg three times weekly had previously made them fatigued. The comment gives neither a weight-loss total nor the second cycle's length.3
For body-composition questions, the useful distinction is between looking leaner, weighing less and gaining muscle. Those are separate outcomes. The accounts here support the writers' descriptions of appearance and performance, without supplying a measured body-composition transformation.
Do better workouts mean MOTS-C builds muscle?
Workout stamina, strength performance and muscle size describe different changes. Completing more of a demanding session can be valuable to the person reporting it, but it does not tell us how much new muscle tissue they gained. A lifting account can describe effort, repetitions or a personal record; a muscle-mass claim needs its own before-and-after measurement.
The research adds an interesting muscle-preservation finding. In a February 2026 study, MOTS-C helped preserve the area and fusion of cultured human muscle cells exposed to dexamethasone, an experimental atrophy challenge. This was a laboratory study of cells. It provides a reason to investigate muscle preservation, while the workout accounts above describe people's subjective training experiences.7
How quickly do people notice results, and how long do they last?
A report posted at week four does not necessarily mean the effect began in week four. It tells us when the writer described the experience. Most accounts provide a point during the routine, rather than a day-by-day record of onset and progression.
The accounts above span an early workout, several weeks of training and a 40-day course. Those time points should stay attached to their specific outcomes. An early energy change and a later appearance change do not combine into a predictable sequence for every reader.
Do the effects continue after stopping?
The positive examples selected here mainly describe experience during use. They do not provide a controlled follow-up showing how long a change lasted after stopping. A proposed break or maintenance plan is different from a documented result after that break.123
Why do some people report less benefit or feel worse?
Public reports also include early benefits that faded, little noticeable change and unwanted effects. These experiences belong alongside the positive accounts because a first impression may differ from the rest of a course.
Early energy, followed by soreness and feeling unwell
Desper84Inspir8ion described 5 mg twice weekly, with clearer thinking, energy and motivation after the first administration. The second felt less striking; the third and fourth brought local soreness and a sick feeling without the same energy improvement. Follow-up disclosed retatrutide, ipamorelin/CJC, testosterone treatment and BPC/TB use. The account therefore describes a changing experience within a multi-compound routine.5
Seven weeks with little noticeable change
In a separate discussion, dos-doxies reported two subjects using 5 mg twice weekly for seven weeks after prior SS-31. They described no noticeable effect beyond mild local reactions. This was the commenter's seven-week experience; the original post's proposed eight-to-ten-week cycle was a different person's plan.6
These accounts cannot determine why an individual responded differently. They also do not show that increasing the amount, adding another compound or extending a course would produce a better result. For symptom-specific information, see the MOTS-C side-effects guide.
Where can you compare the reported schedules and product formats?
The amounts mentioned in these accounts identify what each writer reported. They are not a personal dosing recommendation. The combined dosage, cycles and reconstitution guide puts frequency, weekly quantities, course totals and concentration calculations in one place.
Container size, amount each time and cycle length are separate details. A vial's labelled total does not identify the amount a writer used, and a product photograph does not reveal a completed schedule. The dosage guide explains those quantities with worked examples.
Compare MOTS-C vials and the preloaded autoinjector
View the 10 mg vial, 40 mg vial and 30 mg / 3 mL pen, with the supplied format details and original vial reports.
View MOTS-C productsMOTS-C before-and-after questions
Are these reviews from customers of this website?
No. They are attributed public discussions. We have not verified the writers' identities, product contents or outcomes, and their accounts are not endorsements of this catalog.
Are there verified transformation photos on this page?
This page presents written accounts and stated time points. The source links lead to the original discussions; the selected reports do not supply verified paired transformation photographs.
Does a pen produce different results from a vial?
The selected accounts do not provide a controlled pen-versus-vial comparison. The product page compares labelled amounts and preparation formats; it does not rank them by treatment effect.
Where are the complete benefit and preparation guides?
Open benefits and research for study findings, or dosage and preparation for the reported schedule tables, cycle quantities and working concentration calculator.
Sources and original records
Research claims use original studies or official records. Individual reports are identified as accounts, not clinical evidence.
- 01Public account · flapsucker17, week-four training report ↗
Original post and author's follow-up: training intensity, cardio, final repetitions and concurrent BPC.
- 02Public account · mylastvengeance, five-week cardio report ↗
Original author's reported amounts, modest cardio change and NAD+ disclosure.
- 03Public accounts · 1960s_army_info and johnny2thumbz ↗
Separate comments describing a 40-day leanness account and a second-cycle experience.
- 04Public accounts · early leg-session and three-week training reports ↗
Original author Comfortable-Cry-4117 and the separate commenter Flat_Yak_293; distinct people and routines.
- 05Public account · Desper84Inspir8ion, changing effects across four administrations ↗
Early energy followed by local soreness and feeling unwell; additional compounds disclosed in follow-up.
- 06Public comment · dos-doxies, seven-week experience ↗
Comment describing two subjects; distinct from the original author's proposed eight-to-ten-week schedule.
- 07Elhusseiny et al. · Human muscle-cell study (2026) ↗
Primary laboratory study of MOTS-C and dexamethasone-induced atrophy in cultured human skeletal muscle cells.